LOADING
Comparing Cisco Systems (CSCO) and Pfizer Inc (PFE) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | CSCO | PFE |
|---|---|---|
| Price | $115.53 | $25.75 |
| Change Today | +13.41% | -0.81% |
| Market Cap | $402.4B | $148.0B |
| P/E Ratio | 36.6 | 19.8 |
| Forward P/E | 20.9 | 8.8 |
| PEG Ratio | 1.49 | 13.77 |
| EPS | $2.78 | $1.31 |
| Revenue Growth (YoY) | 9.7% | 5.4% |
| Profit Margin | 18.8% | 11.8% |
| Return on Equity | 23.7% | 8.3% |
| Dividend Yield | 1.65% | 6.65% |
| Beta | 0.91 | 0.30 |
| 52-Week High | $119.36 | $28.28 |
| 52-Week Low | $60.90 | $20.98 |
| Volume | 70.9M | 24.1M |
Cisco Systems is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Cisco Systems has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.